DOCSLIB.ORG

Requiring Staphylococcus Aureus J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Requiring Staphylococcus Aureus J JOURNAL 01 CLINICAL MICROBIOLOGY, Aug. 1978, p. 142-147 Vol. 8, No. 2 0095-1 137/78/0008-0142$02.00/0 Copyright © 1978 American Society for Microbiology Printed in U.S.A. Human Infections Caused by Thiamine- or Menadione- Requiring Staphylococcus aureus J. F. ACAR,' F. W. GOLDSTEIN,' AND P. LAGRANGE2 Hôpital Saint-Joseph, Université Pierre et Marie Curie,' and Institut Pasteur,2 Paris, France Received for publication 21 February 1978 Stable dwarf forms of Staphylococcus aureus have been identified in clinical specimens as the sole or predominant isolate in eight cases. These organisms have been shown to be menadione or thiamine dependent, i.e., cultivation in the presence of one of these agents has permitted growth of colonies which appear typical of S. aureus. In vitro resistance to aminoglycosides was overcome by cultivation in the presence of menadione or thiamine. Menadione- or thiamine- requiring S. aureus can be considered as causative agents in severe human infections. Special care must be taken if they are to be identified in pathological specimens. Their antibiotic sensitivity testing should be done comparatively on supplemented and nonsupplemented media. Staphylococcus aureus growing as dwarf col- onies. S. aureus was identified on the basis of micro- onies on usual media have been documented by scopic morphology, coagulase, phosphatase, deoxyri- many investigators after in vitro exposure of the bonuclease, catalase production, and biochemical tests bacteria to adverse environmental conditions according to Baird-Parker (3). S. aureus 209 P (Insti- tut Pasteur) was used as control. such as chemicals, antibiotics, or aging (4, 8-13, Supplementation of dwarf colony variants. 16, 19, 21-24, 26-29, 37, 39-41, 43-45). In some Dwarf colonies were subcultured by using one or more cases, these organisms have been shown to have of the following media: TSA, TSA with 5% horse increased nutritional requirements, requiring blood, chocolate agar with 1% IsoVitaleX (Baltimore supplementation with carbon dioxide, hemin, Biological Laboratories), Mueller Hinton (MH) agar menadione, thiamine, or pantothenate (6, 10, 12, with disks containing 5 jug of thiamine-hydrochloride 13, 18-20, 22, 23, 26-28, 31-36, 38-41). Isolation (Hoffman-LaRoche) or 1 gg of menadione bisulfite (E. of such strains from clinical material was first Merk AG). Incubation was carried out for 18 and 48 h reported by Hale in 1951 (20). Thiamine-requir- aerobically, aerobically with 5% CO2 supplement, and ing strains isolated et al. as the anaerobically (H2-CO2, GasPak). by Sompolinsky Quantitative supplementation was performed on causative agent of bovine mastitis were never MH agar containing either thiamine or menadione at isolated from human subjects (33-35). Menadi- a 10-fold concentration ranging from 0.01 to 100 ,tg/ml. one-requiring strains similar to those that were The colony size was measured after 18 and 48 h on selected in vitro by Sasarman et al. (27, 28) have each plate. been isolated by Borderon and Horodniceanu Antibiotic sensitivity testing. Disk susceptibility from a clinical specimen (6). testing was performed on MH agar by the ICS method The present study concerns eight strains of S. (15). Dwarf colony variants and reverse mutants of aureus which were isolated as dwarf colonies each strain were tested separately. Zones of inhibition from clinical specimens and which require thia- for kanamycin, gentamicin, erythromycin, lincomycin, mine or to and vancomycin were read after 24 and 48 h of incu- menadione grow normally. The prob- bation at 37°C. A separate test was performed at 30°C lems related to the detection of these strains in with an oxacillin disk to detect methicillin-resistant a clinical laboratory and the methods for testing strains (2). their antibiotic sensitivity are presented here. MIC. Minimal inhibitory concentrations (MICs) of AND the same antibiotics were determined by an agar di- MATERIALS METHODS lution method by using MH agar supplemented with Bacterial strains. From June, 1975, to May, 1976, 5 ,ug of thiamine per ml or 1 ,ug of menadione per ml. among 1,110 strains of S. aureus isolated from clinical Standardized bacterial inocula (102 to 103 colony-form- material, 15 isolates were observed on initial culture ing units per spot) were deposited on the surface of to grow as dwarf colonies on our routine media, Tryp- the agar plates with an automatic Steers replicator ticase soy agar (TSA; Baltimore Biological Laborato- device. Dwarf colony variants and the reverse mutants ries) and TSA with 5% horse blood. Eight of these were tested simultaneously. Results were read after 24 isolates were stable on serial subculture with these and 48 h of incubation. same media and required either thiamine or menadi- Effect of supplementing substances on anti- one to grow as normal-appearing staphylococcal col- biotie sensitivity. (i) Paper strip method. Two 142 VOL. 8, 1978 THIAMINE- OR MENADIONE-REQUIRING S. AUREUS 143 filter paper strips were placed at right angles on an MH agar seeded with 10i colony-forming units per ml by the technique of Bonifas (5) and Dye (14). One paper contained the supplementing substance, and the other contained one of the antibiotics tested by MIC. Concentrations of solutions used for filter paper im- pregnation were (in pg/ml): thiamine, 400, menadione, 100; oxacillin, 100; kanamycin, 200-, gentamicin, 200, erythromycin, 200e, lincomycin, 200; and vancomycin, 400. Checkerboard method. MICs of kanamycin for a thiamine- and a menadione-requiring strain were de- termined by a checkerboard arrangement as described previously (1). Thiamine or menadione at concentra- tions ranging from 0.01 to 100 ug/mI were tested with kanamycin at concentrations ranging from 0.1 to 100 ug/mI in MH broth. Results of growth after 24 and 48 h of incubation at 37°C were drawn as an isobologram on a logarithmic scale. RESULTS Bacterial strain and supplementation. Three menadione- and five thiamine-requiring S. aureus were isolated from specimens obtained from human subjects (Table 1); in most of the cases, dwarf colony variants were recovered as predominant bacteria in mixed cultures with the reverse mutants (Fig. 1). All the strains had normal microscopic morphology and produced coagulase, deoxyribonuclease, and catalase. FIG. 1. Menadione-requiring S. aureus, TSA, 48-h Menadione-requiring strains grew very poorly growth. Some reverse mutants are noted together with after 48 h on all of the nonsupplemented media, dwarf colonies. except on the plate containing the l-,g menadi- one disk where satellite growth with normal- sized colonies occurred around the disk (Fig. 2). Reverse mutants growing normally could be ob- served. Quantitative supplementation tests showed adequate colonial morphology with menadione concentrations ranging from 0.1 to 2 fg/ml. At concentrations higher than 10 gg/ml, growth was inhibited. Thiamine-requiring strains grew poorly on MH agar but had normal appearance on choco- late agar containing IsoVitaleX. On TSA and TS blood agar, intermediary-sized colonies could be observed, probably because these media con- tain a small amount of thia.nne. Reverse mu- tants were isolated from six of the eight strains tested, and three of these strains showed the TABLE 1. Menadione- or thiamine-requiring S. aureus isolated frompatients FIG. 2. Supplementation test, MH agar, 18-h Oitgin No. of iso- Supplement- growth. Satellite growth of menadione-requiring lates ing substance strain around a disk containing I pg of menadione. Blood i Menadione Osteomyelitis 1 Menadione phenomenon of autosatelliting. All of the pri- Subcutaneous abscess i Menadione mary isolates had a heterogenous appearance, Cerebrospinal fluid i Thiamine with a range from normal to tiny variants being Blood 2 Thiamine observed (Fig. 3). Osteomyelitis 2 Thiamine Satellite growth around a disk containing 5 144 ACAR, GOLDSTEIN, AND LAGRANGE J. CLIN. MICROBIOL. ,g of thiamine was very similar to that observed dwarf colonies were lower but did not reach the with a menadione disk. Quantitative supplemen- normal level of the reverse mutants. tation showed adequate colonial morphology at Except for one strain which was highly resist- concentrations ranging from 0.05 to 25 ,ug of ant to erythromycin, all of the strains were in- thiamine. Growth in 5% C02 in air or under hibited by 0.2 ,g of erythromycin per ml, 0.5 ,g anaerobic conditions did not significantly en- of lincomycin per ml, and 1 ,ug of vancomycin hance growth of any thianine- or menadione- per ml. No significant differences relating to requrng strains. colonial morphology or media supplementation Antibiotic sensitivity testing. All of the were observed with these antibiotics. strains tested were sensitive by disk sensitivity Paper strip method. Results obtained by testing to oxacillin, lincomycin, and vancomycin. this method showed that the more a strain is One strain was highly resistant to erythromycin. supplemented with required metabolites, the Results of MIC determinations are presented in greater is its sensitivity to kanamycin and gen- Table 2. Oxacillin inhibited all of the strains at tamicin (Fig. 4). The checkerboard method con- 0.5 ,g/ml. Dwarf colony variants were more firmed this qualitative observation. MICs ofkan- susceptible to oxacillin when tested on nonsup- amycin were higher when thiamine or menadi- plemented media. On media supplemented with one concentrations were decreased. The ratio of thiamine or menadione, dwarf colonies and their MIC on supplemented media to MIC on nonsup- reverse mutants had similar MICs. plemented media was 1/16 for the menadione- Kanamycin and gentamicin inhibited all of requiring strain and 1/4 for the thiamine-requir- the reverse mutants at 1 mg/ml (except for one ing strain. The graphic expression of the MICs strain which was highly resistant to kanamycin). obtained by the checkerboard method is similar In each case, dwarf colony variants had higher to the figure obtained by the paper strip tech- MICs to kanamycin and gentamicin when tested nique (Fig.
Load more

Recommended publications
  • Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus
    Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus human immunodeficiency including Laboratory transmitted infections, diagnosis of sexually Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard, Catherine Ison, David Lewis, Francis Ndowa, Rosanna Peeling For more information, please contact: Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland ISBN 978 92 4 150584 0 Fax: +41 22 791 4171 E-mail: [email protected] www.who.int/reproductivehealth 7892419 505840 WHO_STI-HIV_lab_manual_cover_final_spread_revised.indd 1 02/07/2013 14:45 Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard Catherine Ison David Lewis Francis Ndowa Rosanna Peeling WHO Library Cataloguing-in-Publication Data Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus / edited by Magnus Unemo … [et al]. 1.Sexually transmitted diseases – diagnosis. 2.HIV infections – diagnosis. 3.Diagnostic techniques and procedures. 4.Laboratories. I.Unemo, Magnus. II.Ballard, Ronald. III.Ison, Catherine. IV.Lewis, David. V.Ndowa, Francis. VI.Peeling, Rosanna. VII.World Health Organization. ISBN 978 92 4 150584 0 (NLM classification: WC 503.1) © World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).
    [Show full text]
  • BD™ Columbia Agar with 5% Sheep Blood
    INSTRUCTIONS FOR USE – READY-TO-USE PLATED MEDIA PA-254005.06 Rev.: Apr 2013 BD Columbia Agar with 5% Sheep Blood INTENDED USE BD Columbia Agar with 5% Sheep Blood is a highly nutritious general purpose medium for the isolation and cultivation of nonfastidious and fastidious microorganisms from clinical specimens. PRINCIPLES AND EXPLANATION OF THE PROCEDURE Microbiological method. Ellner et al.1 in 1966 reported the development of a new blood agar formulation, which has been designated as Columbia Agar. BD Columbia Agar with 5% Sheep Blood derives its superior growth-supporting properties from the combination of two peptones, and yeast extract as a supplier of the B complex vitamins. Corn starch is included to absorb toxic by-products contained in the specimen and serves as an energy source for organisms possessing alpha- amylases. Sheep blood allows detection of hemolytic reactions and supplies the X factor (heme) necessary for the growth of many pathogenic species. On this medium, colonies tend to be larger and growth is more luxuriant than on media containing other blood agar bases. Columbia Blood Agar is recommended as a primary isolation medium in the MiQ standards and in other diagnostic manuals.2,3 In many European countries, this medium has become the most frequently used primary isolation medium for clinical specimens. REAGENTS BD Columbia Agar with 5% Sheep Blood Formula* Per Liter Purified Water Pancreatic Digest of Casein 12.0 g Peptic Digest of Animal Tissue 5.0 Yeast Extract 3.0 Beef Extract 3.0 Corn Starch 1.0 Sodium Chloride 5.0 Agar 13.5 Sheep Blood, Defibrinated 5 % pH 7.3 ± 0.2 *Adjusted and/or supplemented as required to meet performance criteria.
    [Show full text]
  • Mikrobiologi Klinik FK UNUD
    CHAPTER 8 Use of Colony Morphology for the Presumptive Identification of Microorganisms George Manuselis, Connie R. Mahon* CHAPTER OUTLINE ■ IMPORTANCE OF COLONIAL MORPHOLOGY AS A Form or Margin DIAGNOSTIC TOOL Elevation ■ INITIAL OBSERVATION AND INTERPRETATION OF Density CULTURES Color ■ GROSS COLONY CHARACTERISTICS USED TO Consistency DIFFERENTIATE AND IDENTIFY MICROORGANISMS Pigment PRESUMPTIVELY Odor Hemolysis ■ COLONIES WITH MULTIPLE CHARACTERISTICS Size ■ GROWTH OF ORGANISMS IN LIQUID MEDIA OBJECTIVES After reading and studying this chapter, you should be able to: 1. Describe how growth on blood, chocolate, and MacConkey agars is 4. Using colonial morphology, differentiate among the following used in the preliminary identification of isolates. microorganisms: 2. Differentiate α-hemolysis from β-hemolysis on blood agar culture • Staphylococci and streptococci medium. • Streptococcus agalactiae and Streptococcus pyogenes 3. Associate the colony characteristics shown on blood, chocolate, and • Neisseria spp. and staphylococci MacConkey agars with the microscopic findings on direct smear, and • Yeast and staphylococci use the information in the presumptive identification of • “Diphtheroids” and staphylococci microorganisms. • Lactose fermenters from lactose nonfermenters • “Swarming” Proteus species from other Enterobacteriaceae Case in Point with a surrounding pink precipitate and a few clear nonlactose fermenting colonies. Based on the Gram stain results and colo- An exudate from a sacral decubital ulcer on a 65-year-old hos- nial characteristics of the isolates, appropriate biochemical tests pital inpatient was cultured on blood agar plate (BAP), chocolate and antibiotic susceptibilities were performed to identify the (CHOC), and MacConkey (MAC) agars. Direct smear examina- causative agents of the ulcer. tion showed many white blood cells, a moderate number of gram-positive cocci in pairs and clusters, and a few gram- negative bacilli.
    [Show full text]
  • Guidelines for Assuring Quality of Medical Microbiological Culture Media July 2012
    Guidelines for Assuring Quality of Medical Microbiological Culture Media July 2012 Guidelines for Assuring Quality of Medical Microbiological Culture Media Culture Media Special Interest Group for the Australian Society for Microbiology, Inc. 2nd edition July 2012 Page 1 of 32 Guidelines for Assuring Quality of Medical Microbiological Culture Media July 2012 FOREWORD to the First Edition The Media Quality Control Special Interest Group of the Australian Society for Microbiology was formed in 1991 by a group of interested individuals after an upsurge in interest in the issue of media quality and the appearance that no common standards or consensus existed in this area in Australia. Increased interest, especially amongst medical microbiologists, in what was being done, or should be done, by way of assuring the quality of microbiological media made the issue contentious. The National Association of Testing Authorities (NATA) Australia, were amongst those seeking guidance in the area of Media Quality Control, being in the position of accrediting microbiology laboratories in the fields of biological testing and medical testing. They found little in the way of consistency and knew of no locally-applicable guidelines on which to base their assessments and recommendations. It fell upon members of the Australian Society for Microbiology, the only professional or learned society in Australia dealing specifically with issues in microbiology, to establish some guidelines. To that end, the Media Quality Control Special Interest Group established a working party to devise a set of guidelines and it was agreed that they should not be dissimilar in content to the standard, Quality Assurance for Commercially Prepared MicrobiologicalCulture Media, Document M22-A, published by the National Committee for Clinical Laboratory, Standards in the USA in 1990.
    [Show full text]
  • Pure Culture Techniques
    Microbiology BIOL 275 PURE CULTURE TECHNIQUES I. OBJECTIVES • To demonstrate good aseptic technique in culture transfer or inoculation and in handling sterile materials. • To demonstrate skill in isolation of organisms from a mixed culture using selective and differential media. • To isolate microorganisms from a wide variety of sources and describe their colonial morphology. II. INTRODUCTION Most environments carry a mixed microbial population. To fully appreciate the contribution of each group of organisms to the ecology of the mass, one must first dissect this mixed culture to obtain single colonies. The single colony is transferred (picked) to a fresh medium to obtain a larger, homogeneous culture that may be studied and characterized by a variety of techniques. One such technique is called aseptic technique. Microbiologists and health workers use this technique to prevent contamination of cultures from outside sources and to prevent the introduction of potential disease agents into the human body (infection can occur through contamination of your hands and clothing with material from your bacterial cultures). Aseptic Techniques Aseptic techniques (also called sterile techniques) are defined as the processes required for transferring a culture from one vessel to another without introducing any additional organisms to the culture or contaminating the environment with the culture. The following conditions must exist for aseptic technique to be successful: 1. The work area must be wiped with an antiseptic to reduce the number of potential contaminants. 2. The transfer instruments must be sterile. 3. The work must be accomplished quickly and efficiently to minimize the time of exposure during which contamination of the culture or laboratory worker can occur.
    [Show full text]
  • Standard Operating Procedure◄
    ►Standard Operating Procedure◄ Section: Laboratory Version: FINAL Initials: AD Title: 2.0 Testing Algorithm Revision Date: 20 Oct 2011 1. Definitions 1.1 SOP: Standard Operating Procedure 1.2 CRF: Case Report Form 2. Purpose / Background 2.1. The purpose of this SOP is to provide guidance for the processing, testing and storage of all PERCH study specimens. 3. Scope / Applicability 3.1. This SOP applies to all laboratory personnel involved in the processing of laboratory specimens. 4. Prerequisites / Supplies Needed 4.1. See test specific SOPs for supplies needed. 5. Roles / Responsibilities [Site specific, as needed] 6. Procedural Steps 6.1 Accepting/Rejecting Specimens: Staff who receive specimens in the laboratory are responsible, to the best of their ability, for ensuring that specimens have been stored and transported under the conditions specified in Appendix 1, Specimen Transport and Storage Conditions. Specimens will only be rejected for processing for the following reasons: (a) specimen is unlabeled (b) specimen ID does not match the requisition form (c) blood is hemolyzed, or anticoagulated specimens contain clots (d) specimen container is leaking. 6.2 Process all study specimens according to the flow charts and specimen preparation tables below. Any departure from the flow charts listed below (e.g. instances of insufficient volume) should be documented as part of the laboratory’s quality management process. For specific processing instructions, please refer to the relevant specimen processing SOP. SOP ID# 2.0 Testing Algorithm version : FINAL Page 2 of 30 *NB As an alternative, all EDTA blood from cases 6.1a can be collected into one tube.
    [Show full text]
  • Neisseria Gonorrhoeae CHAPTER VI
    with Increasing Antimicrobial Resistance Antimicrobial with Increasing Sexually Tr Sexually Sexually Transmitted Bacterialansmitted Pathogen Bacterial Pathogen for which there are Increasing Antimicrobial Resistance Concerns Neisseria gonorrhoeae CHAPTER VI Neisseria gonorrhoeae CONFIRMATORY IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING eisseria gonorrhoeae, also commonly referred to as “gonococcus” or “GC”, causes an estimated 62 million cases of gonorrhea worldwide each year N [Gerbase et al., 1998]. Spread by sexual intercourse, N. gonorrhoeae may infect the mucosal surfaces of urogenital sites (cervix, urethra, rectum) and the oro- and nasopharynx (throat), causing symptomatic or asymptomatic infections. GC is always pathogenic and, if untreated, gonorrhea is a major cause of pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, chronic pelvic pain and/or disseminated gonococcal infection (DGI). The probability of co- infection with other sexually transmitted infections (STIs) may be high in some patient populations. Neonates may acquire gonococcal infection of the conjunctiva during birth. The diagnosis of gonorrhea in older infants and young children is often associated with allegations of sexual abuse; transmission through neither nonsexual human nor fomite contact has been documented. Epidemiological studies provide strong evidence that gonococcal infections facilitate HIV transmission [Fleming and Wasserheit 1999]. Extended-spectrum cephalosporins, fluoroquinolones and spectinomycin are recognized as the most effective antibiotics for the treatment of gonorrhea in most areas of the world. Antimicrobial resistance in N. gonorrhoeae is the most significant challenge to controlling gonorrhea. Gonococcal strains may be resistant to penicillins, tetracyclines, spectinomycin, and, recently, resistance to the fluoroquinolones (ciprofloxacin and ofloxacin) and the macrolide azithromycin has emerged [Handsfield 1994; Knapp et al. 1997; Young et al.
    [Show full text]
  • Georgia Public Health Laboratory Service Manual Director’S Letter
    GGEEOORRGGIIAA PPUUBBLLIICC HHEEAALLTTHH LLAABBOORRAATTOORRYY SSEERRVVIICCEE MMAANNUUAALL 22001133 1 GEORGIA PUBLIC HEALTH LABORATORY SERVICE MANUAL DIRECTOR’S LETTER .......................................................................................................................... 4 ORGANIZATIONAL CHART ................................................................................................................. 5 GEORGIA PUBLIC HEALTH LABORATORY DIRECTORY ............................................................... 6 DIAGNOSTICS LABORATORY SERVICES ........................................................................................ 7 MICROBIOLOGY SERVICES ......................................................................................................... 7 BACTERIOLOGY ............................................................................................................... 8 BORDETELLA PERTUSSIS ............................................................................................................. 8 CHLAMYDIA & GONORRHEA NUCLEIC ACID AMPLIFICATION TEST ...................................... 12 ENTERIC BACTERIOLOGY ........................................................................................................... 17 FOODBORNE OUTBREAKS .......................................................................................................... 21 GONORRHOEA CULTURE ............................................................................................................ 28 THROAT CULTURE FOR GROUP
    [Show full text]
  • Enterobacteriaceae
    ENTEROBACTERIACEAE Enterobacteriaceae family contains a large number of genera that are biochemically and genetically related to one another. This group of organisms includes several that cause primary infections of the human gastrointestinal tract. Members of this family are major causes of opportunistic infection (including septicemia, pneumonia, meningitis and urinary tract infections). Examples of genera that cause opportunistic infections are: Citrobacter, Enterobacter, Escherichia, Hafnia, Morganella, Providencia and Serratia. Escherichia coli live in the human gut and are usually harmless but some are pathogenic causing diarrhea and other symptoms as a result of ingestion of contaminated food or water. Enteropathogenic E. coli (EPEC). Certain serotypes are commonly found associated with infant diarrhea. Enterotoxigenic E. coli (ETEC) produce diarrhea resembling cholera but much milder in degree. They also cause "travelers' diarrhea". Enteroinvasive E. coli (EIEC ) produce a dysentery (indistinguishable clinically from shigellosis, see bacillary dysentery). Enterohemorrhagic E. coli (EHEC). These are usually serotype O157:H7. These organisms can produce a hemorrhagic colitis (characterized by bloody and copious diarrhea with few leukocytes in afebrile patients). The organisms can disseminate into the bloodstream producing systemic hemolytic-uremic syndrome (hemolytic anemia, thrombocytopenia and kidney failure) which is often fatal. The commonest community acquired ("ascending") urinary tract infection is caused by E. coli. Shigella (4 species; S. flexneri, S. boydii, S. sonnei, S. dysenteriae), all cause bacillary dysentery or shigellosis, (bloody feces associated with intestinal pain). The organism invades the epithelial lining layer but does not penetrate. Usually within 2 to 3 days, dysentery results from bacteria damaging the epithelial layers lining the intestine, often with release of mucus and blood (found in the feces) and attraction of leukocytes (also found in the feces as "pus").
    [Show full text]
  • Traditional Culture and Identification Methods 83
    6 © Traditional Culture Images RF/GettyCavan Images and Identification Methods Maria E. Delost, PhD, MT(ASCP) Chapter Outline Introduction Automated Identification Systems Colonial Morphology Matrix-Assisted Laser Desorption Ionization Time of Preliminary Biochemical Tests Flight Mass Spectrometry (MALDI-TOF MS) Multitest Systems Blood Culture Systems Detection of Metabolic Activity Key Terms α hemolytic Colorimetry MALDI-TOF MS Nonhemolytic β hemolytic Fluorometry Nephelometry Phenotypic characteristics Colonial characteristics Learning Objectives Upon successful study and review of this chapter, the learner should be able to: 1. Describe the common bacterial streaking techniques. 7. Discuss the use of manual multitest systems in the 2. Explain the importance of colonial morphology in microbiology laboratory. clinical microbiology. 8. State the principle of the following detection 3. Describe the major phenotypic characteristics used methods and give an application of each: colorim- to evaluate colonial morphology. etry, nephelometry, and fluorometry. 4. Identify and describe the types of hemolysis 9. Describe the principle of MALDI-TOF MS and its observed on sheep blood agar. applications in clinical microbiology. 5. Discuss how the following tests can be used in 10. State the principle of operation and capabilities of the preliminary identification of bacteria: catalase, automated microbiology systems, including identi- cytochrome oxidase, coagulase, PYR hydrolysis, fication and antimicrobial testing. and carbohydrate utilization. 11. Discuss manual and automated blood culture 6. Explain the three methods to detect bacterial systems. metabolism. 81 Copyright © 2022 by Jones & Bartlett Learning, LLC, an Ascend Learning Company 82 Part I Introduction to Clinical Microbiology Introduction primary plates, the microbiologist evaluates the growth to determine if the colonies represent pathogens, normal Traditional methods of identification usingphenotypic microbiota, or contaminants.
    [Show full text]
  • MALDI-TOF MS) Test Procedure
    UK Standards for Microbiology Investigations Matrix-assisted laser desorption/ionisation - time of flight mass spectrometry (MALDI-TOF MS) test procedure Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Test Procedures | TP 40 | Issue no: 1.1 | Issue date: 27.11.19 | Page: 1 of 22 © Crown copyright 2019 Matrix-assisted laser desorption/ionisation - time of flight mass spectrometry (MALDI-TOF MS) test procedure Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the medical editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality-
    [Show full text]
  • Identification of Pseudomonas Species and Other Non-Glucose Fermenters
    UK Standards for Microbiology Investigations Identification of Pseudomonas species and other Non- Glucose Fermenters Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 17 | Issue no: 3 | Issue date: 13.04.15 | Page: 1 of 41 © Crown copyright 2015 Identification of Pseudomonas species and other Non-Glucose Fermenters Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories
    [Show full text]